Custom Search

Friday, February 2, 2007

 

Adult Stem Cell Biotech and Industry


One of the most famous companies is Osiris Therapeutics Inc.
The above chart shows you that the stock price of Osiris Therapeutics has been doubled since its IPO (inital public offering) on Aug 4, 2006, from about $10 to more than $20 a share. This happened only in less than 6 months! Don't you think stem cell biotech is a good investment opportunity?
Osiris Therapeutics has three products in clinical trials:
This company is expanding and recruiting many new employees, particularly technicians and scientists. Good chances for biology masters and Ph.Ds to jump into stem cell industry!

Source: CNN money
Comments:
As an investor, Stem Cell Stocks look promising...here's an article i found about Stem Cell Stocks...

Investing in Stem Cell Stocks

=Cheers!
 
Post a Comment

Subscribe to Post Comments [Atom]





<< Home

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]